Skip to main content

Researchers find a way to create a renewable supply of cancer-fighting T cells

Researchers at the University of California, Los Angeles have made a major advance in the battle against cancer by showing that it’s possible to create mature T cells with important cancer-killing receptors from pluripotent stem cells.

This was achieved by using structures called artificial thymic organoids, which mimic the environment of the thymus, referring to the organ in which T cells develop from blood stem cells.

Recommended Videos

“Using living T cells to kill cancer cells is one of the most exciting areas of cancer treatment,” Christopher Seet, a clinical instructor in the David Geffen School of Medicine at UCLA, told Digital Trends. “The idea here would be to use self-renewing pluripotent stem cells to make unlimited numbers of T cells in the lab, which could be used directly in patients. With certain tweaks, pluripotent stem cells can be genetically engineered to make T cells that would work in any individual. [This] could make T cell immunotherapies cheaper and more widely available. Currently, T cell therapies use a patient’s own T cells and it takes time and great expense to genetically engineer these T cells and give them back to the patient. In some cases, patients may not qualify if they’re too sick, don’t have enough T cells, or the cell quality is not good enough. Faster and cheaper ‘off-the-shelf’ approaches to T cell therapies are badly needed to bring these treatments to more patients.”

This “off-the-shelf” approach could ultimately work to make T cell therapies more accessible, more affordable, and — perhaps most importantly — more effective. There’s still a way to go until this work rolls out to patients, but it is extremely promising.

“Our next goal is to engineer the pluripotent stem cells to make T cells that are suited for treating any individual,” Seet continued. “To do this we need to make sure that the T cells we make are not rejected by a patient’s immune system, and also specifically attack a patient’s tumor cells and not the rest of their body. We can achieve this by engineering these traits in the stem cells, and indeed our goal is to make T cells that not only can be given to any individual, but may function better than T cells from the blood.”

A paper describing the work was recently published in the journal Cell Stem Cell. Other researchers on the work included Gay Crooks and Amélie Montel-Hagen.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
The UK’s Wayve brings its AI automated driving software to U.S. shores
wayve ai automated driving us driver assist2 1920x1152 1

It might seem that the autonomous driving trend is moving at full speed and on its own accord, especially if you live in California.Wayve, a UK startup that has received over $1 billion in funding, is now joining the crowded party by launching on-road testing of its AI learning system on the streets of San Francisco and the Bay Area.The announcement comes just weeks after Tesla unveiled its Robotaxi at the Warner Bros Studios in Burbank, California. It was also in San Francisco that an accident last year forced General Motors’ robotaxi service Cruise to stop its operations. And it’s mostly in California that Waymo, the only functioning robotaxi service in the U.S., first deployed its fleet of self-driving cars. As part of its move, Wayve opened a new office in Silicon Valley to support its U.S. expansion and AI development. Similarly to Tesla’s Full-Self Driving (FSD) software, the company says it’s using AI to provide automakers with a full range of driver assistance and automation features.“We are now testing our AI software in real-world environments across two continents,” said Alex Kendall, Wayve co-founder and CEO.The company has already conducted tests on UK roads since 2018. It received a huge boost earlier this year when it raised over $1 billion in a move led by Softbank and joined by Microsoft and Nvidia. In August, Uber also said it would invest to help the development of Wayve’s technology.Just like Tesla’s FSD, Wayve’s software provides an advanced driver assistance system that still requires driver supervision.Before driverless vehicles can legally hit the road, they must first pass strict safety tests.So far, Waymo’s technology, which relies on pre-mapped roads, sensors, cameras, radar, and lidar (a laser-light radar), is the only of its kind to have received the nod from U.S. regulators.

Read more
Aptera’s 3-wheel solar EV hits milestone on way toward 2025 commercialization
Aptera 2e

EV drivers may relish that charging networks are climbing over each other to provide needed juice alongside roads and highways.

But they may relish even more not having to make many recharging stops along the way as their EV soaks up the bountiful energy coming straight from the sun.

Read more
Ford ships new NACS adapters to EV customers
Ford EVs at a Tesla Supercharger station.

Thanks to a Tesla-provided adapter, owners of Ford electric vehicles were among the first non-Tesla drivers to get access to the SuperCharger network in the U.S.

Yet, amid slowing supply from Tesla, Ford is now turning to Lectron, an EV accessories supplier, to provide these North American Charging Standard (NACS) adapters, according to InsideEVs.

Read more